Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
The Journal of Investigative Dermatology
|
May 1, 1995
An allele of the interleukin-1 receptor antagonist as a genetic severity factor in alopecia areata
M J Cork, J K Tarlow, F E Clay, et al.
Human Genetics
|
February 18, 2003
Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata
R Tazi-Ahnini, M J Cork, D Wengraf, et al.
The British Journal of Dermatology
|
July 12, 2008
The autoimmune regulator gene (AIRE) is strongly associated with vitiligo
R Tazi-Ahnini, A J G McDonagh, D A Wengraf, et al.
Heredity
|
November 13, 2001
Association analysis of IL1A and IL1B variants in alopecia areata
R Tazi-Ahnini, A J McDonagh, A Cox, et al.
Tissue Antigens
|
January 16, 2008
Genetic analysis of autoimmune regulator haplotypes in alopecia areata
D A Wengraf, A J G McDonagh, T R J Lovewell, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics
|
February 14, 2002
Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction
R Tazi-Ahnini, A Cox, A J G McDonagh, et al.
Journal of the American Academy of Dermatology
|
June 1, 1996
Cyclosporine in severe childhood atopic dermatitis: a multicenter study
J Berth-Jones, A Y Finlay, I Zaki, et al.
The British Journal of Dermatology
|
January 1, 1997
Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis
J K Tarlow, M J Cork, F E Clay, et al.
The British Journal of Dermatology
|
December 2, 2017
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)
M de Bruin-Weller, D Thaçi, C H Smith, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 2, 2021
Randomized controlled pilot trial with ion-exchange water softeners to prevent eczema (SOFTER trial)
Z K Jabbar-Lopez, B Ezzamouri, A Briley, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
The Journal of Investigative Dermatology
|
May 1, 1995
An allele of the interleukin-1 receptor antagonist as a genetic severity factor in alopecia areata
M J Cork, J K Tarlow, F E Clay, et al.
Human Genetics
|
February 18, 2003
Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata
R Tazi-Ahnini, M J Cork, D Wengraf, et al.
The British Journal of Dermatology
|
July 12, 2008
The autoimmune regulator gene (AIRE) is strongly associated with vitiligo
R Tazi-Ahnini, A J G McDonagh, D A Wengraf, et al.
Heredity
|
November 13, 2001
Association analysis of IL1A and IL1B variants in alopecia areata
R Tazi-Ahnini, A J McDonagh, A Cox, et al.
Tissue Antigens
|
January 16, 2008
Genetic analysis of autoimmune regulator haplotypes in alopecia areata
D A Wengraf, A J G McDonagh, T R J Lovewell, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics
|
February 14, 2002
Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction
R Tazi-Ahnini, A Cox, A J G McDonagh, et al.
Journal of the American Academy of Dermatology
|
June 1, 1996
Cyclosporine in severe childhood atopic dermatitis: a multicenter study
J Berth-Jones, A Y Finlay, I Zaki, et al.
The British Journal of Dermatology
|
January 1, 1997
Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis
J K Tarlow, M J Cork, F E Clay, et al.
The British Journal of Dermatology
|
December 2, 2017
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)
M de Bruin-Weller, D Thaçi, C H Smith, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 2, 2021
Randomized controlled pilot trial with ion-exchange water softeners to prevent eczema (SOFTER trial)
Z K Jabbar-Lopez, B Ezzamouri, A Briley, et al.
Page
of 8